Cita APA

López Miranda, E., Pérez García, J. M., Di Cosimo, S., Brain, E., Ravnik, M., Escrivá de Romaní, S., . . . Cortés, J. (2020). Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial.

Citación estilo Chicago

López Miranda, Elena, et al. Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. 2020.

Cita MLA

López Miranda, Elena, et al. Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial. 2020.